XASX
LGP
Market cap13mUSD
Oct 09, Last price
0.06AUD
1D
1.59%
1Q
-8.57%
IPO
-86.09%
Name
Little Green Pharma Ltd
Chart & performance
P/E
—
P/S
0.46
EPS
—
Div yield, %
—
Shrs. gr., 5y
18.98%
Rev. gr., 5y
80.67%
Revenues
42m
+15.21%
Net income
-1m
L
CFO
39k
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Little Green Pharma Ltd, established in 2016 and based in West Perth, Australia, specializes in the worldwide cultivation, manufacturing, and distribution of medicinal cannabis products. Its extensive product range encompasses cannabis flower medicines, various cannabis extracts, tinctures, and active pharmaceutical ingredients (APIs), serving markets both within Australia and internationally.
Key people
Non-Executive Independent Chairman of the Board · since 2021
Paul Long
Chief Executive Officer, Managing Director · since 2025
Angus Caithness
Executive Director
Fleta Solomon
Executive Director · since 2025
Alistair Warren
Company Secretary · since 2020
Neale Fong
Non-Executive Independent Director
IPO date
Feb 20, 2020
Employees
120
Domiciled in
AU
Incorporated in
AU
Headquarters & legal address
7/55 Hampden Rd
Nedlands 6009
AU
Nedlands 6009
AU
Previous name
Habi Pharma Pty Ltd
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2023‑03 | 2022‑03 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||